INVA Sep 2024 17.500 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 02:48PM EDT. Market open.
| Previous Close | 0.6000 |
| Open | 0.6000 |
| Bid | 0.0000 |
| Ask | 2.9000 |
| Strike | 17.50 |
| Expire Date | 2024-09-20 |
| Day's Range | 0.6000 - 0.6000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 13 |
Simply Wall St.Calculating The Fair Value Of Innoviva, Inc. (NASDAQ:INVA)
Key Insights Innoviva's estimated fair value is US$19.59 based on 2 Stage Free Cash Flow to Equity Current share price...
Business WireInnoviva to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
BURLINGAME, Calif., June 03, 2024--Innoviva, Inc. (Nasdaq: INVA) ("Innoviva" or the "Company"), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics ("IST"), and a portfolio of strategic investments in healthcare assets, today announced that Pavel Raifeld, Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami, FL
- GuruFocus.com
Innoviva Inc (INVA) Reports First Quarter 2024 Earnings: A Detailed Analysis
Strong Performance with Significant Growth in Net Product Revenue
© 2024 Yahoo. All rights reserved.